Scalper1 News
Celgene and Amgen are among the highly rated companies on IBD’s Screen Of The Day, Bolting RS Lines. The Relative Strength line measures how a stock performs compared to the S&P 500 index. RS lines hitting new highs before the actual stock is a bullish sign. Today’s screen features five drugmakers whose Relative Strength line is bolting higher and whose RS Rating for the current week is above 90, meaning that they have outperformed 90% of all Scalper1 News
Scalper1 News